Nona-arginine

Star0

DB12648InvestigationalSmall molecule

Nona-arginine is under investigation in clinical trial NCT00264706 (PolyArginine Treated vEiN grafTs (PATENT)).

Formula / weight: C₅₄H₁₁₀N₃₆O₁₀ · 1423.716 g/mol (avg)
Also known as: Nona-L-arginine

Resolves to

Compound

UNIIPK7O6W0U44CAS143413-47-2ChEMBLCHEMBL4090674PubChem25077438

Structure

InChIKeyXUNKPNYCNUKOAU-VXJRNSOOSA-NSMILES

N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O

Targets

P35228NOS2

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Nona-arginine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account